Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag, Astrazeneca AbfiledCriticalBayer Schering Pharma Ag
Priority to CU20100227ApriorityCriticalpatent/CU20100227A7/en
Publication of CU20100227A7publicationCriticalpatent/CU20100227A7/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Un compuesto de fórmula Ia: ESPACIO PARA LA FÓRMULA La presente invención se refiere a nuevos derivados de indazolilo, a composiciones farmacéuticas que comprenden tales derivados, a procesos para preparar dichos nuevos derivados y al uso de tales derivados como medicamentos.A compound of formula Ia: SPACE FOR FORMULA The present invention relates to new derivatives of indazolyl, pharmaceutical compositions comprising such derivatives, processes for preparing said new derivatives and the use of such derivatives as medicaments.
CU20100227A2010-11-192010-11-19
DERIVATIVES OF INDAZOLS REPLACED WITH PHENYLL OR PIRIDINYL
CU20100227A7
(en)
Analog compounds of epoxyeicosatrienoic acid, ethers agonists; pharmaceutical composition; and use of the compounds to prepare useful medications to treat hypertension and induced nephrotoxicity medications, such as cisplatin.
Use of compounds derived from iron (iii) pyrimidin-2-ol-1-oxide complexes and pharmaceutically acceptable compositions thereof containing at least one ligand of formula (i) because they serve to prepare a medicament.